Joshua Weiyuan Wang

Founder at PathoVax LLC

Commercial Services

Health Technology

Profile

Joshua Weiyuan Wang is the founder of PathoVax LLC, where he holds the title of Chief Executive Officer & Director since 2014.
Dr. Wang is also the founder of Verimmune, Inc.

Joshua Weiyuan Wang active positions

Companies	Position	Start
PathoVax LLC PathoVax LLC Miscellaneous Commercial ServicesCommercial Services PathoVax LLC engages in the provision of biotechnology services. It focuses on medical applications for its proprietary Papillomavirus Virus-like Particle platform. The company was founded by Joshua Wang, Weijie Poh, and Nicholas Calcaterra in 2014 and is headquartered in Baltimore, MD.	Founder	2013-12-31
Verimmune, Inc. Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.	Chief Executive Officer	-

All active positions of Joshua Weiyuan Wang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joshua Weiyuan Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
PathoVax LLC PathoVax LLC Miscellaneous Commercial ServicesCommercial Services PathoVax LLC engages in the provision of biotechnology services. It focuses on medical applications for its proprietary Papillomavirus Virus-like Particle platform. The company was founded by Joshua Wang, Weijie Poh, and Nicholas Calcaterra in 2014 and is headquartered in Baltimore, MD.	Commercial Services
Verimmune, Inc. Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then.	Health Technology